PMID- 26192086 OWN - NLM STAT- MEDLINE DCOM- 20160105 LR - 20230216 IS - 1530-0307 (Electronic) IS - 0023-6837 (Linking) VI - 95 IP - 10 DP - 2015 Oct TI - Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells. PG - 1157-73 LID - 10.1038/labinvest.2015.91 [doi] AB - Epithelial-to-mesenchymal transition (EMT) and apoptosis of peritoneal mesothelial cells are known to be the earliest mechanisms of peritoneal fibrosis in peritoneal dialysis (PD). Endoplasmic reticulum (ER) stress with an unfolded protein response is regarded to have a role in the development of organ fibrosis. To investigate the potential role of ER stress as a target to prevent and/or delay the development of peritoneal fibrosis, we examined the effect of ER stress on EMT or apoptosis of human peritoneal mesothelial cells (HPMCs) and elucidated the mechanisms underlying the protective effect of ER stress preconditioning on TGF-beta1-induced EMT. ER stress inducers, tunicamycin (TM) and thapsigargin (TG), induced EMT with Smad2/3 phosphorylation, an increased nuclear translocation of beta-catenin and Snail expression. Low concentrations of TM and TG did not induce apoptosis within 48 h; however, high concentrations of TM- (>1 ng/ml) and TG- (>1 nM) induced apoptosis at 12 h with a persistent increase in C/EBP homologous protein. TGF-beta1 induced EMT and apoptosis in HPMCs, which was ameliorated by taurine-conjugated ursodeoxycholic acid, an ER stress blocker. Interestingly, pre-treatment with TM or TG for 4 h also protected the cells from TGF-beta1-induced EMT and apoptosis, demonstrating the role of ER stress as an adaptive response to protect HPMCs from EMT and apoptosis. Peritoneal mesothelial cells isolated from PD patients displayed an increase in GRP78/94, which was correlated with the degree of EMT. These findings suggest that the modulation of ER stress in HPMCs could serve as a novel approach to ameliorate peritoneal damage in PD patients. FAU - Shin, Hyun-Soo AU - Shin HS AD - Department of Internal Medicine, Division of Nephrology, Ewha Medical Research Center, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. FAU - Ryu, Eun-Sun AU - Ryu ES AD - Department of Internal Medicine, Division of Nephrology, Ewha Medical Research Center, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. FAU - Oh, Eok-Soo AU - Oh ES AD - Department of Life Sciences, Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea. FAU - Kang, Duk-Hee AU - Kang DH AD - Department of Internal Medicine, Division of Nephrology, Ewha Medical Research Center, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150720 PL - United States TA - Lab Invest JT - Laboratory investigation; a journal of technical methods and pathology JID - 0376617 RN - 0 (Anti-Bacterial Agents) RN - 0 (CTNNB1 protein, human) RN - 0 (Endoplasmic Reticulum Chaperone BiP) RN - 0 (HSPA5 protein, human) RN - 0 (Membrane Transport Modulators) RN - 0 (Nuclear Localization Signals) RN - 0 (SMAD2 protein, human) RN - 0 (SMAD3 protein, human) RN - 0 (Smad2 Protein) RN - 0 (Smad3 Protein) RN - 0 (Snail Family Transcription Factors) RN - 0 (Transcription Factors) RN - 0 (Transforming Growth Factor beta1) RN - 0 (beta Catenin) RN - 11089-65-9 (Tunicamycin) RN - 67526-95-8 (Thapsigargin) SB - IM MH - Anti-Bacterial Agents/adverse effects MH - *Apoptosis MH - Ascitic Fluid/metabolism/pathology MH - Cells, Cultured MH - Endoplasmic Reticulum Chaperone BiP MH - *Endoplasmic Reticulum Stress MH - *Epithelial-Mesenchymal Transition MH - Gene Expression Regulation/drug effects MH - Humans MH - Membrane Transport Modulators/adverse effects MH - *Models, Biological MH - Nuclear Localization Signals/drug effects/metabolism MH - Peritoneal Dialysis/*adverse effects MH - Peritoneal Fibrosis/chemically induced/etiology/metabolism/*pathology MH - Phosphorylation/drug effects MH - Protein Processing, Post-Translational/drug effects MH - Smad2 Protein/metabolism MH - Smad3 Protein/metabolism MH - Snail Family Transcription Factors MH - Thapsigargin/adverse effects MH - Transcription Factors/genetics/metabolism MH - Transforming Growth Factor beta1/metabolism MH - Tunicamycin/adverse effects MH - *Unfolded Protein Response MH - beta Catenin/metabolism EDAT- 2015/07/21 06:00 MHDA- 2016/01/06 06:00 CRDT- 2015/07/21 06:00 PHST- 2015/02/18 00:00 [received] PHST- 2015/04/18 00:00 [revised] PHST- 2015/05/12 00:00 [accepted] PHST- 2015/07/21 06:00 [entrez] PHST- 2015/07/21 06:00 [pubmed] PHST- 2016/01/06 06:00 [medline] AID - S0023-6837(22)01368-X [pii] AID - 10.1038/labinvest.2015.91 [doi] PST - ppublish SO - Lab Invest. 2015 Oct;95(10):1157-73. doi: 10.1038/labinvest.2015.91. Epub 2015 Jul 20.